MCID: DSM004
MIFTS: 65

Desmoid Tumor malady

Categories: Genetic diseases, Rare diseases, Cancer diseases, Muscle diseases

Aliases & Classifications for Desmoid Tumor

About this section
Sources:
65UMLS, 45NIH Rare Diseases, 23Genetics Home Reference, 47Novoseek, 51Orphanet, 28ICD10 via Orphanet
See all MalaCards sources

Aliases & Descriptions for Desmoid Tumor:

Name: Desmoid Tumor 45 23 47 51
Familial Infiltrative Fibromatosis 45 23
Aggressive Fibromatosis 23 51
Fibromatosis, Familial Infiltrative 45
Musculo-Aponeurotic Fibromatosis 65
Musculoaponeurotic Fibromatosis 23
Desmoid Disorder, Hereditary 45
 
Desmoid Disease, Hereditary 65
Hereditary Desmoid Disease 23
Desmoid Type Fibromatosis 51
Fibromatosis, Aggressive 65
Desmoid Fibromatosis 23
Deep Fibromatosis 23
Fif 45

Characteristics:

Orphanet epidemiological data:

51
desmoid tumor:
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Europe); Age of onset: Adolescent,Adult; Age of death: normal life expectancy

Classifications:

Orphanet: 51 
Rare tumors


External Ids:

Orphanet51 873
ICD10 via Orphanet28 D48.1
UMLS65 C0079218, C1851124, C1297884

Summaries for Desmoid Tumor

About this section
Genetics Home Reference:23 A desmoid tumor is an abnormal growth that arises from connective tissue, which is the tissue that provides strength and flexibility to structures such as bones, ligaments, and muscles. Typically, a single tumor develops, although some people have multiple tumors. The tumors can occur anywhere in the body. Tumors that form in the abdominal wall are called abdominal desmoid tumors; those that arise from the tissue that connects the abdominal organs are called intra-abdominal desmoid tumors; and tumors found in other regions of the body are called extra-abdominal desmoid tumors. Extra-abdominal tumors occur most often in the shoulders, upper arms, and upper legs.

MalaCards based summary: Desmoid Tumor, also known as familial infiltrative fibromatosis, is related to fibrosarcoma and prostate cancer, and has symptoms including anomalies of the abdominal wall, subcutaneous nodules/lipomas/tumefaction/swelling and muscle anomalies. An important gene associated with Desmoid Tumor is CTNNB1 (Catenin Beta 1), and among its related pathways are Presenilin action in Notch and Wnt signaling and Nectin adhesion pathway. Affiliated tissues include bone, breast and lung, and related mouse phenotypes are adipose tissue and limbs/digits/tail.

Wikipedia:68 Aggressive fibromatosis is a rare condition marked by the presence of desmoid tumors. Desmoid tumors can... more...

Related Diseases for Desmoid Tumor

About this section

Diseases related to Desmoid Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 160)
idRelated DiseaseScoreTop Affiliating Genes
1fibrosarcoma29.3CDKN2A, KIT, PDGFRA, PDGFRB, RB1
2prostate cancer28.5CCND1, CDH2, CDKN1B, CTNNB1, MKI67, PDGFRB
3gastrointestinal stromal tumor28.4ACTC1, CDKN2A, KIT, MKI67, PDGFRA, PDGFRB
4lung cancer27.9CCND1, CDH2, CDKN1B, CDKN2A, CTNNB1, PCNA
5breast cancer27.6APC, CCND1, CDKN1B, CTNNB1, KIT, MKI67
6familial adenomatous polyposis10.9
7fibrous meningioma10.7APC, CTNNB1, MKI67
8iron metabolism disease10.7APC, CTNNB1, PTGS2
9adenomatous polyposis coli10.7
10amelogenesis imperfecta hypomaturation type10.6CDKN2A, MKI67
11breast angiomatosis10.6CCND1, CDKN2A
12fibromatosis10.6
13childhood disintegrative disease10.6CCND1, CDKN2A, PTGS2
14bowing of legs, anterior with dwarfism10.6CCND1, CDKN2A, PTGS2
15common variable immunodeficiency10.6APC, CTNNB1, PTGS2
16biliary tract neoplasm10.5APC, CCND1, CTNNB1, PTGS2
17ulnar neuropathy10.5APC, CCND1, CTNNB1, PTGS2
18ameloblastoma10.5CDKN2A, CTNNB1, RB1
19myxoid chondrosarcoma10.5CDKN2A, CTNNB1, RB1
20molluscum contagiosum10.5CDKN2A, MKI67, PTGS2
21severe canavan disease10.5PDGFRA, PDGFRB
22oral lichen planus10.5CDKN2A, MKI67, PCNA
23mediastinal neurilemmoma10.4CTNNB1, KIT, PTGS2
24charcot-marie-tooth disease10.4CDKN2A, CTNNB1, MKI67
25splenogonadal fusion limb defects micrognatia10.4CDKN2A, MKI67
26primary thrombocytopenia10.4CDKN2A, MKI67, PTGS2
27estrogen-receptor positive breast cancer10.4CCND1, CDKN2A, PTGS2
28pyometritis10.4CDKN2A, CTNNB1, PTGS2
29vasculitis10.4CCND1, CDKN2A, CTNNB1
30tracheal lymphoma10.3CCND1, CDKN2A, CTNNB1
31proctitis10.3CCND1, CDKN2A, CTNNB1, PTGS2
32farber lipogranulomatosis10.3CCND1, CDKN2A, MKI67, PTGS2
33hypothalamic disease10.3CCND1, CDKN2A, CTNNB1
34non-invasive bladder urothelial carcinoma10.3APC, CCND1, CTNNB1, MKI67, PTGS2
35restless legs syndrome10.3APC, CCND1, CTNNB1, PTGS1, PTGS2
36lymphatic neoplasm10.3DES, PCNA
37hartnup disorder10.3CCND1, CDKN2A, PTGS2
38progressive muscular atrophy10.3CCND1, CDKN2A, MKI67, PCNA
39desmoid disease, hereditary10.3
40oral leukoplakia10.3CCND1, CDKN2A, PCNA, PTGS2
41pancreatic somatostatinoma10.3CCND1, CDKN2A, CTNNB1
42adenosquamous pancreas carcinoma10.2CDKN2A, PDGFRA, PTGS2
43gliosarcoma10.2CCND1, CDKN2A, MKI67, PDGFRB
44connective tissue benign neoplasm10.2CDKN2A, KIT, PTGS2
45extraneural perineurioma10.2KIT, PDGFRA
46organ system benign neoplasm10.2APC, CCND1, CDKN2A, CTNNB1, PTGS2
47zimmermann-laband syndrome 210.2CCND1, CDKN2A, PTGS2, RB1
48juxtacortical chondroma10.2CCND1, MKI67, PCNA
49pancreatitis10.2
50pediatric fibrosarcoma10.2CTNNB1, KIT, PDGFRA

Graphical network of the top 20 diseases related to Desmoid Tumor:



Diseases related to desmoid tumor

Symptoms for Desmoid Tumor

About this section

Symptoms:

 51 (show all 21)
  • anomalies of the abdominal wall
  • subcutaneous nodules/lipomas/tumefaction/swelling
  • muscle anomalies
  • fibromatosis/bone fibroma
  • soft tissue sarcoma/cancer/tumor/liposarcoma/myosarcoma
  • polyposis of the bowel/colon/intestine
  • acute abdominal pain/colic
  • myalgia/muscular pain
  • retinitis pigmentosa/retinal pigmentary changes
  • skin tumors/lumps/epidermal cysts
  • malabsorption/chronic diarrhea/steatorrhea
  • gastrointestinal bleeding/hemorrhage/hematemesis/melena/rectorrhagia
  • intestinal obstruction/ileus
  • thoracic/chest pain
  • bladder and ureter anomalies
  • megaureter/hydronephrosis/pyeloureteral junction syndrome
  • osteolysis/osteoclasia/bone destruction/erosions
  • articular/joint pain/arthralgia
  • restricted joint mobility/joint stiffness/ankylosis
  • early death/lethality
  • sepsis severe/septicemia

Drugs & Therapeutics for Desmoid Tumor

About this section

Drugs for Desmoid Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 83)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
ErythromycinapprovedPhase 492114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E.e.s
E.e.s.
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Ery-ped
Ery-tab
Eryacne
Eryacnen
Erybid
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythra-derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
 
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin Base
Erythromycin Base Base
Erythromycin Base Filmtab
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
2Erythromycin stearatePhase 492
3Gastrointestinal AgentsPhase 46401
4Erythromycin EthylsuccinatePhase 492
5Erythromycin EstolatePhase 492
6Anti-Bacterial AgentsPhase 4, Phase 1, Phase 29140
7Anti-Infective AgentsPhase 4, Phase 1, Phase 217220
8
Fentanylapproved, illicit, investigationalPhase 3705437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Abstral
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl - Novaplus
Fentanyl Citrate
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
 
Fentanyl-12
Fentanyl-25
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Lazanda
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Subsys
UNII-UF599785JZ
fentanyl
9
Sorafenibapproved, investigationalPhase 3671284461-73-0216239, 406563
Synonyms:
284461-73-0
4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
AB1004622
AC-1674
AC1L50CF
BAX
BAY 43-9006
BAY 43-9006 (free base)
BAY 43-9006 tosylate salt
BAY 439006
BAY 54-9085 (tosylate salt)
BAY-43-0006
BAY-43-9006
BAY-54-9085
BAY43-9006
BRD-K23984367-001-01-8
Bio-0100
CHEBI:47228
CHEBI:50924
CHEMBL1336
CID216239
 
D08524
DB00398
DB07438
EN002709
I06-0856
K00597a
Kinome_766
LS-186067
LS-187021
LS-187788
MolPort-003-850-270
N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
NCGC00167488-01
NSC-724772
NSC747971
Nexavar
STK627350
Sorafenib
Sorafenib (INN)
Sorafenib Tosylate
Sorafenib [INN]
Sorafenib tosylate
Sorafenibum
UNII-9ZOQ3TZI87
ZINC01493878
nchembio.117-comp17
sorafenib
sorafenibum
10
Folic Acidapproved, nutraceuticalPhase 3, Phase 2292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
11
Niacinapproved, investigational, nutraceuticalPhase 336159-67-6938
Synonyms:
3-Carboxylpyridine
3-Carboxypyridine
3-Pyridinecarboxylate
3-Pyridinecarboxylic acid
3-Pyridylcarboxylate
3-Pyridylcarboxylic acid
3-carboxypyridine
Acide Nicotinique
Acido nicotinico
Acidum Nicotinicum
Akotin
Anti-pellagra vitamin
Apelagrin
Daskil
Efacin
Enduracin
Linic
M-Pyridinecarboxylic Acid
Niac
Niacin
Niacine
Niacor
Niaspan
Niaspan ER
Nicacid
Nicamin
 
Nicangin
Nico-Span
Nicobid
Nicocap
Nicodelmine
Nicolar
Niconacid
Nicosan 3
Nicotinate
Nicotinic Acid
Nicotinic acid
Nicotinipca
Nicyl
Nikotinsaeure
Nyclin
P.P. factor
PP Factor
Pellagra preventive factor
Pellagrin
Pelonin
Pyridine-beta-carboxylic acid
Slo-niacin
Vitamin B3
Wampocap
beta-Pyridinecarboxylic acid
pyridine-β-carboxylic acid
β-pyridinecarboxylic acid
12NarcoticsPhase 32709
13Peripheral Nervous System AgentsPhase 3, Phase 218510
14Vitamin B ComplexPhase 3, Phase 22847
15pancreatic polypeptidePhase 320
16Central Nervous System DepressantsPhase 310016
17AnestheticsPhase 3, Phase 27385
18Analgesics, OpioidPhase 32304
19AnalgesicsPhase 3, Phase 29358
20Liver ExtractsPhase 3, Phase 13572
21Anesthetics, GeneralPhase 32274
22Protein Kinase InhibitorsPhase 3, Phase 2, Phase 13162
23Anesthetics, IntravenousPhase 31943
24VitaminsPhase 33857
25Trace ElementsPhase 33900
26Nicotinic AcidsPhase 3361
27MicronutrientsPhase 33901
28ColaNutraceuticalPhase 3, Phase 11768
29Vitamin B9NutraceuticalPhase 3, Phase 22924
30FolateNutraceuticalPhase 3, Phase 22924
31
Nicotinamideexperimental, NutraceuticalPhase 335398-92-0936
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
37321-14-5
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC-907/25014114
AC1L1ACZ
AC1Q4ZFV
AI3-02906
Acid amide
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra Brand of Niacinamide
Austrovit PP
B 3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin Amide
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
Hansamid
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
LS-2051
MLS000069714
Mediatric
Merck Brand of Niacinamide
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
NCGC00093354-03
NCGC00093354-04
NSC 13128
NSC13128
NSC27452
Nandervit-N
Niacevit
Niacinamide
Niacinamide (USP)
Niacinamide Astra Brand
Niacinamide Jenapharm Brand
Niacinamide Merck Brand
 
Niacinamide Pharmagenix Brand
Niacinamide [USAN]
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid Jenapharm
Nicotinsaureamid [German]
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
PP-Faktor
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix Brand of Niacinamide
Propamine A
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
SGCUT00176
SMR000058212
Savacotyl
UNII-25X51I8RD4
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin B 3
Vitamin B3
Vitamin H1
Vitamin PP
WLN: T6NJ CVZ
Witamina PP
ZINC00005878
b-Pyridinecarboxamide
beta-Pyridinecarboxamide
bmse000281
m-(Aminocarbonyl)pyridine
nchembio.154-comp4
nchembio.73-comp6
niacin - Vitamin B3
niacinamide
nicotinamide
pyridine-3-carboxamide
to_000073
vitamin PP
32Vitamin B3NutraceuticalPhase 3361
33
Sunitinibapproved, investigationalPhase 2486341031-54-7, 557795-19-45329102
Synonyms:
(2S)-2-hydroxybutanedioic acid
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)
326914-13-0
341031-54-7
5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE
557795-19-4
AC1NS62J
AC1O5CMQ
AKOS005145765
Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
CHEBI:38940
CHEBI:550864
CHEMBL1567
CHEMBL535
CID5329102
CID6456015
D06402
D08552
DB01268
DB07417
EN002687
FT-0083555
FT-0083556
I01-1229
K00588a
KS-5022
LS-186078
LS-187023
LS-187648
MolPort-003-986-763
N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate
N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
NCGC00164631-01
 
NSC736511
NSC750690
PDGF TK antagonist
PHA-290940AD
PNU-290940AD
S1042_Selleck
ST51053712
SU 011248
SU 11248
SU-010398
SU-011248 L-malate salt
SU-11248
SU-11248 L-malate salt
SU-11248J
SU-12662
SU010398
SU011248
SU011248 L-malate salt
SU11248
Su-011248
Sunitanib
Sunitinib
Sunitinib (INN)
Sunitinib (free base)
Sunitinib Malate
Sunitinib malate
Sunitinib malate (JAN/USAN)
Sunitinib malate [USAN]
Sunitinibum
Sutent
Sutent (TN)
Sutent, SU-11248
TL8002546
UNII-LVX8N1UT73
UNII-V99T50803M
sunitinib
sunitinibum
34
Toremifeneapproved, investigationalPhase 22589778-26-73005573
Synonyms:
(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)-N,N-dimethyl-ethylamine citrate(1:1)
2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC)
2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine
2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
89778-26-7
89778-27-8 (citrate (1:1))
98644-21-4
AC-1751
AC1MHJ33
Acapodene
BIDD:ER0222
BIDD:GT0211
BIDD:PXR0202
C08166
CCRIS 8745
CHEBI:9635
CHEMBL1655
CID3005573
D08620
DB00539
Estrimex
 
FC-1157a
Fareston
Farestone
GTX-006 (Acapodene)
GTx 006
GTx-006
HMS2090B22
LS-7729
MolPort-002-508-208
NCGC00160530-01
STK626445
STOCK6S-27411
Toremifene (INN)
Toremifene Base
Toremifene Citrate (1:1)
Toremifene [INN:BAN]
Toremifeno
Toremifeno [Spanish]
Toremifenum
Toremifenum [Latin]
UNII-7NFE54O27T
Z-Toremifene
toremifene
{2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine
35
VinblastineapprovedPhase 2230865-21-413342, 241903
Synonyms:
(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine
(2xi,3beta,4'beta,19xi)-vincaleukoblastine
(3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate
143-67-9
1z2b
29060-LE
865-21-4
AC-20335
AC1L21JC
AC1L68D2
AC1MXZJ2
BIDD:PXR0201
BRD-K01188359-065-02-5
BSPBio_001228
BSPBio_003594
Bio-0111
C07201
C46H58N4O9
CCRIS 9002
CHEBI:171516
CHEBI:27375
CHEMBL159
CHEMBL607706
CID13342
CID241903
CID3823887
CID6710780
D08675
DB00570
EINECS 212-734-0
HMS2090K05
HSDB 3263
KBio3_003033
LS-1859
LS-187263
 
MolPort-002-518-262
MolPort-005-910-359
NCGC00022585-04
NCGC00181127-01
NCI-C04842
NCI60_004200
NChemBio.2007.10-comp22
NDC 0002-1452-01
NSC 47842
Neuro_000020
Nincaluicolflastine
Rozevin
SPBio_000680
STOCK1N-38480
Spectrum2_000890
Spectrum3_001994
UNII-5V9KLZ54CY
VLB
VR-8
Velban
Velbe
Vinblastin
Vinblastina
Vinblastina (TN)
Vinblastina [DCIT]
Vinblastina [Dcit]
Vinblastine
Vinblastine (INN)
Vinblastine Sulfate
Vinblastine [INN:BAN]
Vinblastinum
Vinblastinum [INN-Latin]
Vincaleucoblastin
Vincaleucoblastine
Vincaleukoblastine
Vincoblastine
nchembio873-comp22
vinblastine
36
MethotrexateapprovedPhase 214441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
37
EverolimusapprovedPhase 1, Phase 21797159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
Afinitor Disperz
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
VOTUBIA
Zortress
everolimus
38
Miconazoleapproved, investigationalPhase 1, Phase 2302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
39
TamoxifenapprovedPhase 2, Phase 135010540-29-12733526
Synonyms:
(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene
(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine
(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)
(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE
(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
,citrate
1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
10540-29-1
1ya4
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
54965-24-1 (citrate)
AC1MBZ3R
Apo-Tamox
Apo-tamox
BIDD:ER0008
BIDD:GT0009
BIDD:PXR0003
BPBio1_000278
BRD-K93754473-001-02-9
BRD-K93754473-048-05-3
BSPBio_000252
BSPBio_001150
BSPBio_001982
C07108
C26H29NO
CCRIS 3275
CHEBI:41774
CHEMBL83
CID2733526
Citofen
Crisafeno
D08559
DB00675
Diemon
EINECS 234-118-0
Gen-Tamoxifen
Gen-tamoxifen
HMS1362J11
HMS1792J11
HMS1990J11
HMS2090N08
HSDB 6782
ICI 47699
ICI-46,474
ICI-47699
IDI1_000258
IDI1_002170
Istubol
Kessar
L024126
LS-393
Lopac0_001203
MLS001332535
MLS001332536
MolPort-003-850-384
 
NCGC00024928-01
NCGC00024928-03
NCGC00024928-04
NCGC00024928-05
NCGC00024928-07
NCGC00024928-08
NCGC00024928-09
NCGC00024928-12
NSC727681
Noltam
Nolvadex
Nolvadex-D
Nourytam
Novaldex
Novo-Tamoxifen
Oncomox
PMS-Tamoxifen
Pms-Tamoxifen
Prestwick2_000146
Prestwick3_000146
QTL1_000079
Retaxim
SMR000059172
ST50511785
Soltamox
Spectrum5_001417
Spectrum5_002043
T5648_SIGMA
TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1))
TRANS FORM OF TAMOXIFEN
Tamizam
Tamofen
Tamone
Tamoplex (TN)
Tamoxasta
Tamoxen
Tamoxifen
Tamoxifen (INN)
Tamoxifen (TN)
Tamoxifen (Z)
Tamoxifen Citrate
Tamoxifen [INN:BAN]
Tamoxifen and its salts
Tamoxifene
Tamoxifene [INN-French]
Tamoxifeno
Tamoxifeno [INN-Spanish]
Tamoxifenum
Tamoxifenum [INN-Latin]
Tamoxifène
Tocris-0999
Tomaxithen
Trans-Tamoxifen
UNII-094ZI81Y45
UPCMLD-DP027
Valodex
Zemide
cMAP_000044
nchembio.140-comp7
nchembio.76-comp1
nchembio732-comp3
tamoxifen
trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
trans-Tamoxifen
40
Aminolevulinic acidapprovedPhase 2142106-60-5137
Synonyms:
106-60-5
35BEC718-C970-426A-9859-BF58284C60B4
5-ALA
5-Amino-4-oxo-Pentanoate
5-Amino-4-oxo-Pentanoic acid
5-Amino-4-oxopentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Amino-Levulinate
5-Amino-Levulinic acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Aminolevulinate hydrochloride
5-Aminolevulinic acid
5-amino-levulinate
5451-09-2
AC-054
AC1L18K9
AKOS003587520
ALA
ALA-PDT
Aladerm
Amino-levulinic acid
Aminolevulinate
Aminolevulinic
Aminolevulinic acid
BIDD:GT0260
BSPBio_003407
C00430
CCRIS 8958
CHEBI:17549
CHEMBL601
CID137
CPD000857229
 
D07567
DALA
DB00855
DivK1c_006954
EINECS 203-414-1
I14-10101
KBio1_001898
KBio2_002062
KBio2_004630
KBio2_007198
KBio3_002627
KBioGR_001176
KBioSS_002062
Kerastick
LMFA01100055
LS-101793
Levulan Kerastick
Levulinic acid, 5-amino- (8CI)
MLS001333097
MLS001333098
MolPort-001-788-423
NCGC00178086-01
Pentanoic acid, 5-amino-4-oxo- (9CI)
SAM002589919
SMR000857229
SPBio_001843
ST50819610
SpecPlus_000858
Spectrum2_001662
Spectrum3_001654
Spectrum4_000618
Spectrum5_001505
Spectrum_001582
UNII-88755TAZ87
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
delta-aminolevulinic acid
41
Sirolimusapproved, investigationalPhase 1, Phase 2179753123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
42
SulindacapprovedPhase 23538194-50-25352, 1548887
Synonyms:
(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
32004-68-5
38194-50-2
5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
53933-60-1
6301-55-9
9000-14-0
AB00513800
AC-4550
AC1L1K5T
AC1LU7GU
AC1LU7GY
AC1Q6YHK
AKOS004119989
AR-1A9609
Aclin
Aflodac
Alphapharm Brand of Sulindac
Apo Sulin
Apo-Sulin
Apotex Brand of Sulindac
Arthrobid
Arthrocine
BB_SC-1128
BPBio1_000315
BRD-A03427350-001-01-3
BRD-A13946108-001-04-9
BRN 2951842
BSPBio_000285
BSPBio_002890
C01531
C20H17FO3S
CAS-38194-50-2
CCRIS 3305
CHEBI:9352
CHEMBL1376
CID1548885
CID1548887
CID5352
CPD000326718
Cahill May Roberts Brand of Sulindac
Chemia Brand of Sulindac
Chibret
Clinoril
Clinoril (TN)
Copal
Copal resin
Copal rosin varnish
Copals
D00120
D013467
DB00605
DivK1c_000601
EINECS 232-527-9
EINECS 250-893-8
EINECS 253-819-2
EINECS 258-873-0
EU-0101070
Gum copal
HMS1568O07
HMS1921C11
HMS2089J04
HMS2092K15
HMS501O03
I06-0523
IDI1_000601
KBio1_000601
KBio2_001506
KBio2_002320
KBio2_004074
KBio2_004888
KBio2_006642
KBio2_007456
KBio3_002110
KBio3_002800
KBioGR_001571
 
KBioGR_002320
KBioSS_001506
KBioSS_002322
KST-1B6530
Kenalin
Kendrick Brand of Sulindac
Klinoril
LS-81610
Lopac-S-8139
Lopac0_001070
MK 231
MK-231
MK231
MLS001056554
MLS001304027
MLS002207124
Merck Brand of Sulindac
Merck Sharp & Dohme Brand of Sulindac
Mobilin
MolPort-002-507-760
MolPort-003-666-287
NCGC00015970-01
NCGC00015970-02
NCGC00015970-03
NCGC00015970-08
NCGC00025268-01
NCGC00025268-02
NCGC00025268-03
NCGC00094349-01
NCGC00094349-02
NINDS_000601
Novo Sundac
Novo-Sundac
Novopharm Brand of Sulindac
Nu Pharm Brand of Sulindac
Nu Sulindac
Nu-Pharm Brand of Sulindac
Nu-Sulindac
Prestwick0_000073
Prestwick1_000073
Prestwick2_000073
Prestwick3_000073
Prestwick_456
Resin copal
S 8139
S2007_Selleck
S4429_SIAL
S8139_SIAL
S8139_SIGMA
SAM002554933
SBB058181
SMR000043852
SMR000326718
SPBio_001451
SPBio_002206
SPECTRUM1500556
STK802068
Spectrum2_001326
Spectrum3_001365
Spectrum4_000876
Spectrum5_001024
Spectrum_001026
Sulindac
Sulindac (JAN/USP/INN)
Sulindac [USAN:BAN:INN:JAN]
Sulindac sulfoxide
Sulindaco
Sulindaco [INN-Spanish]
Sulindacum
Sulindacum [INN-Latin]
Sulindal
Tocris-1707
UNII-184SNS8VUH
UNII-M5221THD3M
UNM-0000306136
Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid
[(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid
cMAP_000021
cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid
cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid
sulindac
{(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
{(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
{5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid
43Nucleic Acid Synthesis InhibitorsPhase 23836
44Immunosuppressive AgentsPhase 2, Phase 110422
45Tubulin ModulatorsPhase 24279
46Angiogenesis InhibitorsPhase 23688
47Imatinib MesylatePhase 2, Phase 1577123596
48Angiogenesis Modulating AgentsPhase 23611
49Immunologic FactorsPhase 2, Phase 118483
50AntimetabolitesPhase 29454

Interventional clinical trials:

(show all 31)
idNameStatusNCT IDPhase
1Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous PolyposisRecruitingNCT02175914Phase 4
2Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall ReconstructionRecruitingNCT02228889Phase 4
3Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted VersionNot yet recruitingNCT02354560Phase 4
4Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3
5Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive FibromatosisSuspendedNCT02066181Phase 3
6Toremifene in Treating Patients With Desmoid TumorsCompletedNCT00002595Phase 2
7Vinblastine and Methotrexate in Treating Children With Desmoid TumorsCompletedNCT00003019Phase 2
8Radiation Therapy in Treating Patients With Aggressive FibromatosesCompletedNCT00030680Phase 2
9Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasCompletedNCT00474994Phase 2
10A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type FibromatosisRecruitingNCT01265030Phase 1, Phase 2
11PAZOPANIB Efficacy and Tolerance in Desmoids TumorsRecruitingNCT01876082Phase 2
12Imatinib in Patients With Desmoid Tumor and ChondrosarcomaRecruitingNCT00928525Phase 2
13Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids TumorsRecruitingNCT01898416Phase 2
14Imatinib Mesylate in Treating Patients With Recurrent or Refractory FibromatosisRecruitingNCT00287846Phase 1, Phase 2
15Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular TargetsRecruitingNCT02353429Phase 2
16A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)RecruitingNCT02495519Phase 2
17Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive FibromatosisActive, not recruitingNCT01981551Phase 2
18Study to Evaluate Imatinib in Desmoid TumorsActive, not recruitingNCT01137916Phase 2
19Sulindac and Tamoxifen in Treating Patients With Desmoid TumorActive, not recruitingNCT00068419Phase 2
20Effect of Hydroxyurea as Treatment for Primary Desmoid TumorsWithdrawnNCT00978146Phase 2
21MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00020579Phase 1
22Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib MesylateCompletedNCT01046487Phase 1
23Endoxifen in Adults With Hormone Receptor Positive Solid TumorsRecruitingNCT01273168Phase 1
24A Dose Escalation Study of OMP-54F28 in Subjects With Solid TumorsActive, not recruitingNCT01608867Phase 1
25A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner SyndromeCompletedNCT01286662
26Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasCompletedNCT01567046
27Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical TreatmentRecruitingNCT02476305
2818F-FES PET/CT in Imaging Patients With Desmoid TumorsRecruitingNCT02374931
29Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor PatientsRecruitingNCT02547831
30Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaRecruitingNCT00919269
31Optional Sub-study to Intraoperative Imaging With ICG RegistryNot yet recruitingNCT02651246

Search NIH Clinical Center for Desmoid Tumor

Genetic Tests for Desmoid Tumor

About this section

Anatomical Context for Desmoid Tumor

About this section

MalaCards organs/tissues related to Desmoid Tumor:

33
Bone, Breast, Lung, Kidney, Prostate, Colon, Thyroid

Animal Models for Desmoid Tumor or affiliated genes

About this section

MGI Mouse Phenotypes related to Desmoid Tumor:

38 (show all 31)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053759.1APC, CDKN1B, PCNA, PDGFRB, PTGS2, RB1
2MP:00053718.8APC, CTNNA1, CTNNB1, KIT, PDGFRA, PDGFRB
3MP:00053708.2APC, CDKN1B, CDKN2A, CTNNB1, KIT, PDGFB
4MP:00053828.0APC, CCND1, CDKN1B, CTNNA1, CTNNB1, KIT
5MP:00011867.8APC, CDKN1B, CDKN2A, CTNNA1, CTNNB1, KIT
6MP:00053677.7APC, CDKN1B, CTNNB1, KIT, PDGFB, PDGFRA
7MP:00028737.6ACTC1, APC, CCND1, CTNNB1, KIT, MKI67
8MP:00053917.6APC, CCND1, CDKN1B, CDKN2A, CTNNA1, CTNNB1
9MP:00053817.6APC, CCND1, CDKN1B, CDKN2A, CTNNB1, KIT
10MP:00030127.5APC, CDKN1B, CDKN2A, CTNNB1, KIT, PCNA
11MP:00053807.5APC, CDH2, CDKN2A, CTNNA1, CTNNB1, KIT
12MP:00020067.4APC, CCND1, CDKN1B, CDKN2A, CTNNA1, CTNNB1
13MP:00053887.3CCND1, CDKN1B, CDKN2A, CTNNB1, KIT, PDGFB
14MP:00053907.2APC, CCND1, CDKN2A, CTNNA1, CTNNB1, KIT
15MP:00053867.2APC, CCND1, CDKN1B, CDKN2A, CTNNB1, DES
16MP:00053797.1APC, CCND1, CDKN1B, CDKN2A, CTNNA1, CTNNB1
17MP:00053896.8APC, CCND1, CDKN1B, CDKN2A, CTNNB1, KIT
18MP:00107716.6APC, CCND1, CDKN1B, CDKN2A, CTNNA1, CTNNB1
19MP:00036316.5APC, CCND1, CDH2, CDKN1B, CDKN2A, CTNNA1
20MP:00053876.3APC, CCND1, CDKN1B, CDKN2A, CTNNB1, KIT
21MP:00053976.2APC, CCND1, CDKN1B, CDKN2A, CTNNB1, KIT
22MP:00053845.5ACTC1, APC, CCND1, CDH2, CDKN1B, CDKN2A
23MP:00053695.2ACTC1, APC, CDH2, CDKN1B, CDKN2A, CTNNA1
24MP:00053765.1ACTC1, APC, CCND1, CDH2, CDKN1B, CDKN2A
25MP:00053785.0ACTC1, APC, CCND1, CDH2, CDKN1B, CDKN2A
26MP:00053854.7ACTC1, APC, CCND1, CDH2, CDKN1B, CDKN2A
27MP:00107684.0ACTC1, APC, CCND1, CDH2, CDKN1B, CDKN2A

Publications for Desmoid Tumor

About this section

Articles related to Desmoid Tumor:

(show top 50)    (show all 451)
idTitleAuthorsYear
1
Sporadic intra-abdominal desmoid tumor: a unusual presentation. (27150282)
2016
2
EXTRA-ABDOMINAL DESMOID TUMOR: LOCAL RECURRENCE AND TREATMENT OPTIONS. (27217816)
2016
3
Concomitant surgical treatment of a chondrosarcoma of the chest wall and a desmoid tumor of the gastrointestinal tract. (26336503)
2015
4
Desmoid Tumor of the Popliteal Fossa during Pregnancy. (25734019)
2015
5
Desmoid tumor fistulating to small bowel. (25820514)
2015
6
Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution. (24789435)
2014
7
A rare presentation of a large extra-abdominal desmoid tumor of the posterior neck and back. (24035615)
2013
8
Desmoid tumor of the facet joint: a case report. (24757464)
2013
9
Desmoid tumor of posterior cruciate ligament of the knee: a case report. (23432794)
2013
10
Lipomatosis of the sciatic nerve secondary to compression by a desmoid tumor. (23801100)
2013
11
The desmoid tumor: still an enigma. (21435664)
2012
12
Intra-thoracic desmoid tumor. (22628932)
2012
13
Desmoid tumor of the buttock in a preadolescent child. (22953269)
2011
14
A massive abdominal wall desmoid tumor occurring in a laparotomy scar: a case report. (21426541)
2011
15
Mifepristone (RU486), a pure antiprogesterone drug, in combination with vinblastine for the treatment of progesterone receptor-positive desmoid tumor. (20585823)
2010
16
Becker nevus with an underlying desmoid tumor: a case report and review including Mayo Clinic's experience. (21173323)
2010
17
Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). (20187095)
2010
18
Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options. (20305341)
2010
19
A rare case of desmoid tumor of thigh. (21966144)
2010
20
Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence. (18704758)
2009
21
Chest wall desmoid tumor with life-threatening intrathoracic extension. (19162501)
2009
22
Common peroneal nerve palsy following TNF-based isolated limb perfusion for irresectable extremity desmoid tumor. (19944662)
2009
23
A case of mesenteric desmoid tumor of the jejunum. (19942588)
2009
24
Sporadic desmoid tumor in an Ashkenazi patient homozygous for the APC*I1307K gene mutation. (18770064)
2008
25
Anterior mediastinal desmoid tumor with CT and MR imaging. (17721335)
2007
26
Intra-abdominal desmoid tumor following retroperitoneal lymph node dissection for testicular germ cell tumor. (16448440)
2006
27
Development and rapid growth of a desmoid tumor in the surgical corridor after suboccipital craniotomy for recurrent low-grade astrocytoma. (16645711)
2006
28
Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor). (15674349)
2005
29
Desmoid tumor of the subscapularis presenting as isolated loss of external rotation of the shoulder. A report of two cases. (14711961)
2004
30
Bilateral ureteral compression by multiple abdominal desmoid tumors in Gardner syndrome: case report and literature review. (15533508)
2004
31
Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). (14534534)
2003
32
Sporadic hereditary pancreatic desmoid tumor: a new entity? (12869894)
2003
33
Quiz case. Extraabdominal desmoid tumor of the upper arm. (14652152)
2003
34
Intrathoracic desmoid tumor mimicking primary lung neoplasm. (11383835)
2001
35
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). (10597266)
1999
36
Recurring desmoid tumor of the foot: a case study. (9167934)
1997
37
Recurring desmoid tumor of the foot: a case study. (8696499)
1996
38
Sequential treatment of recurrent mesenteric desmoid tumor. (8635124)
1996
39
Deletion 5q in desmoid tumor and fluorescence in situ hybridization for chromosome 8 and/or 20 copy number. (8976374)
1996
40
Desmoid tumor of the ulna in a patient with neurofibromatosis. (8583048)
1995
41
Mesenteric desmoid tumor 19 years after radiation therapy for testicular seminoma. (7974887)
1994
42
Case report 771: Melorheostosis in association with desmoid tumor. (8316873)
1993
43
Gardner syndrome and desmoid tumors. (8266758)
1993
44
Paratesticular desmoid tumor. (3576898)
1987
45
Desmoid tumor of the paraspinous muscle involving the chest wall. (3929184)
1985
46
Dystrophic and psammomatous calcifications in a desmoid tumor. A light microscopic and ultrastructural study. (3965088)
1985
47
The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. (7091046)
1982
48
Desmoplastic fibroma vs. desmoid tumor of bone. Two cases illustrating a problem in differential diagnosis and classification. (6025046)
1967
49
Extensive recurrent desmoid tumor of the abdominal wall: radical excision followed by reconstruction of the abdominal wall with plastic procedure. (13073476)
1953
50
Desmoid tumor. (21019323)
1946

Variations for Desmoid Tumor

About this section

Expression for genes affiliated with Desmoid Tumor

About this section
Search GEO for disease gene expression data for Desmoid Tumor.

Pathways for genes affiliated with Desmoid Tumor

About this section

Pathways related to Desmoid Tumor according to GeneCards Suite gene sharing:

(show top 50)    (show all 59)
idSuper pathwaysScoreTop Affiliating Genes
19.9APC, CCND1, CTNNB1
29.8CTNNA1, CTNNB1, PDGFRB
39.7CCND1, CTNNA1, CTNNB1
4
Show member pathways
9.7CDH2, CTNNA1, CTNNB1
59.7CDH2, CTNNA1, CTNNB1
69.7CDH2, CTNNA1, CTNNB1
79.7CDH2, CTNNA1, CTNNB1
89.7CDKN2A, CTNNB1, RB1
99.7CCND1, CDKN1B, PDGFRB
109.6APC, CCND1, CTNNB1, PTGS2
119.6CCND1, CDKN2A, RB1
12
Show member pathways
9.6CCND1, CDKN1B, RB1
139.5APC, CDH2, CTNNA1, CTNNB1
149.5APC, PCNA, RB1, SERPINE1
159.4CDKN1B, CTNNB1, PTGS1, PTGS2
16
Show member pathways
9.4CCND1, CDKN2A, PCNA, SERPINE1
179.4CCND1, CDKN1B, PTGS2, RB1
189.3APC, CCND1, CTNNA1, CTNNB1, SERPINE1
199.3CCND1, CDKN1B, PCNA, RB1
209.2CCND1, CDKN1B, CDKN2A, RB1
21
Show member pathways
9.2CCND1, CDKN1B, CDKN2A, RB1
22
Show member pathways
9.2CCND1, CDKN1B, CDKN2A, RB1
239.2PDGFB, PDGFRA, PDGFRB
24
Show member pathways
9.2PDGFB, PDGFRA, PDGFRB
259.2PDGFB, PDGFRA, PDGFRB
269.2CCND1, CDKN1B, KIT, PTGS2
27
Show member pathways
9.1APC, CCND1, CDKN1B, CDKN2A, CTNNB1
289.1APC, CCND1, CDH2, CTNNA1, CTNNB1, PTGS2
29
Show member pathways
9.0CCND1, CDKN1B, CDKN2A, RB1, SERPINE1
309.0CDH2, PDGFB, PDGFRA, PDGFRB
319.0CDKN1B, CDKN2A, PCNA, RB1, SERPINE1
328.9ACTC1, CDH2, CTNNA1, CTNNB1
33
Show member pathways
8.9CCND1, CDKN1B, PDGFRA, PDGFRB, RB1
34
Show member pathways
8.8APC, CCND1, CTNNA1, CTNNB1, KIT, PCNA
358.7ACTC1, KIT, PDGFRA
368.6CDH2, DES, KIT, PDGFB
37
Show member pathways
8.6APC, CTNNB1, PDGFB, PDGFRA, PDGFRB, RB1
388.5CCND1, CDKN1B, CDKN2A, MCM5, PCNA, RB1
39
Show member pathways
8.5CCND1, CDKN1B, CDKN2A, MCM5, PCNA, RB1
408.4APC, CCND1, CDKN1B, CTNNB1, PCNA, PDGFRA
41
Show member pathways
8.3ACTC1, CDH2, CTNNA1, CTNNB1, DES
428.2CCND1, CDKN1B, KIT, PDGFB, PDGFRA, PDGFRB
43
Show member pathways
8.0APC, CDKN1B, CTNNB1, KIT, PDGFB, PDGFRA
44
Show member pathways
7.9CCND1, CDKN1B, CTNNB1, PDGFB, PDGFRA, PDGFRB
457.9APC, CCND1, CDKN1B, CDKN2A, PDGFB, PDGFRA
46
Show member pathways
7.8CCND1, CDKN1B, CDKN2A, CTNNB1, PDGFB, PDGFRA
477.7APC, CCND1, CDKN2A, CTNNB1, PCNA, PDGFB
487.6APC, CCND1, CDKN1B, CDKN2A, CTNNB1, PDGFB
496.6APC, CCND1, CDKN1B, CDKN2A, CTNNA1, CTNNB1
50
Show member pathways
5.7APC, CCND1, CDH2, CDKN1B, CDKN2A, CTNNA1

GO Terms for genes affiliated with Desmoid Tumor

About this section

Cellular components related to Desmoid Tumor according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein complexGO:00432349.8APC, CDH2, CTNNB1

Biological processes related to Desmoid Tumor according to GeneCards Suite gene sharing:

(show all 39)
idNameGO IDScoreTop Affiliating Genes
1cyclooxygenase pathwayGO:001937110.7PTGS1, PTGS2
2myoblast differentiationGO:004544510.6CTNNB1, RB1
3cellular response to indole-3-methanolGO:007168110.6CTNNA1, CTNNB1
4positive regulation of muscle cell differentiationGO:005114910.6CTNNA1, CTNNB1
5striated muscle cell differentiationGO:005114610.5CDH2, RB1
6positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathwayGO:003579310.4PDGFB, PDGFRB
7maintenance of blood-brain barrierGO:003563310.4PTGS1, PTGS2
8positive regulation of DNA biosynthetic processGO:200057310.3PDGFB, PDGFRB
9retina vasculature development in camera-type eyeGO:006129810.3PDGFRA, PDGFRB
10somatic stem cell divisionGO:004810310.2CDKN2A, KIT
11response to cadmium ionGO:004668610.2CDKN1B, CTNNB1, PCNA
12cell cycle arrestGO:000705010.2APC, CDKN2A, RB1
13positive regulation of chemotaxisGO:005092110.1PDGFB, PDGFRB
14negative regulation of cyclin-dependent protein serine/threonine kinase activityGO:004573610.0APC, CDKN1B, CDKN2A
15adherens junction organizationGO:003433210.0CDH2, CTNNA1, CTNNB1
16negative regulation of platelet activationGO:001054410.0PDGFB, PDGFRA
17Ras protein signal transductionGO:00072659.9CDKN2A, PDGFRB, RB1
18positive regulation of cyclin-dependent protein serine/threonine kinase activityGO:00457379.9CCND1, CDKN1B, PDGFB
19positive regulation of phospholipase C activityGO:00108639.8KIT, PDGFRA, PDGFRB
20transmembrane receptor protein tyrosine kinase signaling pathwayGO:00071699.8KIT, PDGFRA, PDGFRB
21regulation of phosphatidylinositol 3-kinase signalingGO:00140669.7PDGFB, PDGFRA, PDGFRB
22positive regulation of phosphatidylinositol 3-kinase signalingGO:00140689.7KIT, PDGFRA, PDGFRB
23platelet-derived growth factor receptor signaling pathwayGO:00480089.7PDGFB, PDGFRA, PDGFRB
24wound healingGO:00420609.7PDGFB, PDGFRA, PDGFRB
25response to organonitrogen compoundGO:00102439.5CCND1, PTGS1, PTGS2
26phosphatidylinositol-mediated signalingGO:00480159.4CDKN1B, KIT, PDGFRA, PDGFRB
27positive regulation of DNA replicationGO:00457409.4PCNA, PDGFB, PDGFRA
28G1/S transition of mitotic cell cycleGO:00000829.2CCND1, CDKN1B, MCM5, PCNA, RB1
29positive regulation of phosphatidylinositol 3-kinase activityGO:00435529.2KIT, PDGFB, PDGFRA, PDGFRB
30cell chemotaxisGO:00603269.1KIT, PDGFB, PDGFRA, PDGFRB
31response to estrogenGO:00436279.1CCND1, CTNNA1, CTNNB1, PDGFB, PDGFRB
32activation of MAPKK activityGO:00001869.0KIT, PDGFB, PDGFRA, PDGFRB
33insulin receptor signaling pathwayGO:00082869.0KIT, PDGFB, PDGFRA, PDGFRB
34vascular endothelial growth factor receptor signaling pathwayGO:00480108.9CTNNA1, KIT, PDGFB, PDGFRA
35fibroblast growth factor receptor signaling pathwayGO:00085438.8CDKN1B, KIT, PDGFB, PDGFRA, PDGFRB
36response to estradiolGO:00323558.7CCND1, CDKN1B, CTNNB1, PDGFB, PDGFRB, PTGS2
37response to drugGO:00424938.7ACTC1, APC, CTNNB1, PDGFB, PTGS2
38response to organic cyclic compoundGO:00140708.5CCND1, CDKN1B, CTNNA1, CTNNB1, PDGFB, PTGS2
39regulation of cell proliferationGO:00421278.5CDKN1B, CTNNB1, KIT, PDGFB, PTGS1, PTGS2

Molecular functions related to Desmoid Tumor according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1gamma-catenin bindingGO:00452959.7APC, CDH2, CTNNA1
2platelet-derived growth factor bindingGO:00484079.7PDGFRA, PDGFRB
3vascular endothelial growth factor bindingGO:00380859.5PDGFRA, PDGFRB

Sources for Desmoid Tumor

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet